COVID-19 vaccine: Bharat Biotech ready to share formula of Covaxin with other manufacturers, says Centre
Amid a political war of words between the Centre and the Delhi government over the availability of sufficient vaccines to inoculate all adults in the national capital, the central government has said that leading drug maker Bharat Biotech is ready to share the formula of its anti-COVID vaccine COVAXIN with other manufacturers.
May 14, 2021, 09:01 AM IST
DNA: DGCI approves Covaxin clinical trials for 2-18 year olds
The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".
May 13, 2021, 22:26 PM IST
Vaccine mix-up! Maharashtra man given two doses of different COVID-19 vaccines, under observation
Dattatraya Waghmare was given the first jab of Covaxin on March 22 at a rural hospital. For the second dose, which he got on April 30 at a primary health centre in Shrishti village, he was administered Covishield.
May 13, 2021, 16:33 PM IST
Covaxin gets green signal to begin trials
Considering that the ongoing second wave is affecting children and the third wave of covid to be catastrophic for kids, vaccinating kids against the COVID-19 virus is needed.
May 13, 2021, 12:56 PM IST
50 employees of Bharat Biotech test COVID-19 positive; Joint MD's tweet sparks concern
The Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, Bihar, Jharkhand and Delhi.
May 13, 2021, 12:43 PM IST
Bharat Biotech's Covaxin gets DCGI nod to conduct clinical trials on children above 2 years
The national drug regulator said that it has accepted the recommendation of the SEC “after careful examination” and accorded permission to Covaxin manufacturer Bharat Biotech.
May 13, 2021, 11:52 AM IST
Maharashtra halts COVID vaccination for 18-44 age group, people above 45 to be given priority
The Maharashtra Health Minister also revealed that the Serum Institute of India (SII) has informed the Maharashtra government that it would be able to provide 1.5 crore Covishield vaccines to the state only May 20 onwards.
May 12, 2021, 20:30 PM IST
Bharat Biotech refused vaccine supply, mismanagement by Centre, says Manish Sisodia
Addressing a press conference, he said that the Delhi government had asked for 67 lakh Covaxin doses but the manufacturer has refused it citing central government’s directions in addition to shortage of doses.
May 12, 2021, 15:38 PM IST
Coronavirus Update: Covaxin gets approval for trials on 2-18 year-olds
Bharat Biotech's Covaxin gets approval for next phase of trials on 2-18 year-olds.
May 12, 2021, 11:02 AM IST
Bharat Biotech's Covaxin gets approval for phase 2/3 trials on 2-18 year-olds
The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organization (CDSCO) on Tuesday deliberated upon Hyderabad-based Bharat Biotech's application seeking permission to conduct phase II/III clinical trials to evaluate the safety, reactogenicity and immunogenicity of Covaxin jabs in children aged 2 to 18 years.
May 12, 2021, 08:48 AM IST
COVID Alert: Delhi runs out of Covaxin stock for people in 18-44 age group
Delhi has run out of Covaxin stock for people in the 18-44 age group and will have to shut 125 centres where the coronavirus vaccine was being administered, AAP MLA Atishi said.
May 11, 2021, 18:36 PM IST
Konkona gets the vax, shares tips on how to get slot on CoWin site
Konkona Sensharma urged everyone to be extra careful post vaccination process.
May 11, 2021, 15:31 PM IST
All about the COVID-19 vaccines available in India, pricing and other details
May 11, 2021, 12:51 PM IST
Delhi has only one day's Covaxin stock left, says Health Minister Satyendar Jain
Delhi Health Minister Satyendar Jain said Delhi has only one day's Covaxin stock left and its Covishield doses will last for just three to four days.
May 10, 2021, 18:44 PM IST
India set to get 5 million doses of Russian COVID vaccine Sputnik V by June: Venkatesh Varma
Sputnik V is the 3rd vaccine India has given approval to after the University of Oxford, AstraZeneca vaccine COVISHIELD and Indian Vaccine manufactured by Bharat Biotech--COVAXIN.
Apr 30, 2021, 14:53 PM IST
Bharat Biotech slashes Covaxin rates for states to Rs 400
Bharat Biotech said in a statement, "We have made Covaxin available to state governments at a price of 400/ dose."
Apr 29, 2021, 21:53 PM IST
Bombay HC refuses to hear PIL seeking uniform rate of COVID-19 vaccines, tells petitioner to move SC
The Bombay High Court on Thursday refused to hear a PIL seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of Rs 150 (plus GST) per dose.
Apr 29, 2021, 13:20 PM IST
Delaying COVID vax will give virus opportunity to develop new variants
People should not delay taking COVID-19 vaccine as this will give virus an opportunity to develop new variants and some of them may reduce the efficacy of current vaccines, say healthcare experts.
Apr 28, 2021, 16:35 PM IST
India's Covaxin found to neutralise 617 variant of COVID-19, says top US medical advisor Dr Anthony Fauci
Developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research, Covaxin was approved for emergency use on January 3. Trial results later showed the vaccine has an efficacy of 78 per cent.
Apr 28, 2021, 13:42 PM IST
Serum Institute, Bharat Biotech asked to lower COVID-19 vaccine price: Official source
The central government on Monday asked the Serum Institute and Bharat Biotech to lower prices of their COVID-19 vaccines amid criticism from various states who objected to profiteering during such a major crisis.
Apr 26, 2021, 19:49 PM IST
